BALPHARMA.BOBALPHARMA.BOBSE
Loading
Revenue ContractionContracting
Percentile Rank86
3Y CAGR+2.5%
5Y CAGR+12.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+2.5%/yr
vs +7.7%/yr prior
5Y CAGR
+12.1%/yr
Recent deceleration
Acceleration
-5.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$3.03B-10.7%
2024$3.39B+11.5%
2023$3.04B+8.2%
2022$2.81B+13.9%
2021$2.47B+44.3%
2020$1.71B-24.0%
2019$2.25B+7.5%
2018$2.09B-8.6%
2017$2.29B+15.4%
2016$1.98B-